![]() Spermine structure
|
Common Name | Spermine | ||
---|---|---|---|---|
CAS Number | 9015-13-8 | Molecular Weight | 202.340 | |
Density | 0.9±0.1 g/cm3 | Boiling Point | 308.4±0.0 °C at 760 mmHg | |
Molecular Formula | C10H26N4 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 175.6±22.6 °C |
Optimized Treatment of Heparinized Blood Fractions to Make Them Suitable for Analysis.
Biopreserv. Biobank. 13 , 287-95, (2015) It has been known for decades that many cytokines, such as IL-2, IL-6, and IL-12, bind to heparin. Even though some enzyme-linked immunosorbent assays (ELISA) use antibody-recognizing epitopes not affected by this binding, ELISA manufacturers often warn that ... |
|
A modified thromboelastographic method for monitoring c7E3 Fab in heparinized patients.
Anesth. Analg. 84 , 31-38, (1997) The monoclonal antibody, c7E3 Fab, binds to the platelet surface fibrinogen receptor (GPIIb/IIIa), inhibiting platelet aggregation and clot retraction. We performed an in vitro study to assess the ability of a modification of the thromboelastograph (MTEG) to ... |
|
Improved high-performance liquid chromatographic method to estimate aminosugars and its application to glycosaminoglycan determination in plasma and serum.
J. Chromatogr. B. Biomed. Sci. Appl. 765 , 151-160, (2001) An improved isocratic high-performance liquid chromatography (HPLC) method for the analysis of L-(-)-fucose. D-(+)-galactosamine, D-(+)-glucosamine, D-(+)-galactose, obtained by hydrolysis of glycosaminoglycans (GAGs) and D-(+)-glucose and D-(+)-mannose is de... |
|
Characteristics of the interactions between acid glycosaminoglycans and proteins in normal human plasma as revealed by the behaviour of the protein-polysaccharide complexes in ultrafiltration and chromatographic procedures.
Clin. Chim. Acta 206 , 167-180, (1992) Acid glycosaminoglycans were isolated from normal human plasma: (a) following fractionation of plasma (with protease inhibitors) on Sephadex G-200; (b) by ultrafiltration through membranes with retention of molecules above 50 kDa, with and without previous ad... |
|
Monitoring heparin therapy: relationships between the activated partial thromboplastin time and heparin assays based on ex-vivo heparin samples.
Thromb. Haemost. 63(1) , 16-23, (1990) Five different APTT-reagents, two amidolytic anti-IIa assays, one amidolytic anti-Xa assay, and one coagulometric anti-Xa/anti-IIa assay were used to assess the effect of heparin in patients treated for venous thromboembolic disease. Good correlations were ob... |
|
Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing.
Blood Coagul. Fibrinolysis 4(4) , 635-8, (1993) The prolongation of the APTT and PT by heparin can be neutralized by treating the plasma with heparinase or with certain anion-exchangers. The purpose of the present study was to assess the effectiveness of a new commercial heparinase reagent. Heparinase (Hep... |
|
Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin-induced thrombocytopenia (HIT).
J. Thromb. Haemost. 5(3) , 636-7, (2007)
|